Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
A recent report from the Institute for Clinical and Economic Review, an independent nonprofit that evaluates the value of medical treatments, found that GLP-1s such as Ozempic, Wegovy and Zepbound are cost-effective, meaning the medication's health benefits justify their price
Armed with this personalized data, you and your PlexusDx provider can refine your dosing strategy with confidence, potentially avoiding ineffective dose levels and accelerating your path to the right therapeutic window
Tirzepatide targets two receptors (GLP-1 and GIP), which may produce stronger appetite suppression for some patients
Kim J-Y, van de Wall E, Laplante M, et al
The result at week 88: Continued tirzepatide: :Lost an additional 5.5% of body weight (total loss from baseline: ~25%) Switched to placebo: Regained 14.0% of body weight (net loss from baseline: ~9%) A 19-point swing between continued and discontinued groups
US$ 20.18
US$ 24.40
US$ 29.77
US$ 27.06
US$ 20.83
.png)
US$ 20.70
US$ 26.59
